Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9EGB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $40,298
Award facts
- Contract value 100% obligated
- $40,297.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $40,297.66 delivery order to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on February 3, 2026, for the supply of Cosentyx Unoready 300 mg pens in 2 mL quantities. This is a firm fixed-price delivery order with an ultimate completion date of February 4, 2026, and represents a non-set-aside award made through open competition. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen serves as a critical vendor to the federal government, particularly supporting military and veteran healthcare systems through its extensive pharmaceutical distribution capabilities.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999.00 and extending through December 2026. The IDC enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities. The DLA Troop Support Medical maintains this prime vendor relationship to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with flexible and efficient pharmaceutical procurement.
Quick answers
Who was awarded contract SPE2DR26F9EGB?
SPE2DR26F9EGB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 3, 2026.
How much is contract SPE2DR26F9EGB worth?
The government has obligated $40,298 on SPE2DR26F9EGB.
Is contract SPE2DR26F9EGB an order under another contract?
Yes. SPE2DR26F9EGB is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9EGB competed?
The extent of competition for SPE2DR26F9EGB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award